Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Checkmate Pharmaceuticals, Inc. - Common Stock (NQ:CMPI)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Checkmate Pharmaceuticals, Inc. - Common Stock

CHECKMATE PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI
From Kahn Swick & Foti, LLC
Via Business Wire
CHECKMATE PHARMACEUTICALS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkmate Pharmaceuticals, Inc. - CMPI
From Kahn Swick & Foti, LLC
Via Business Wire
CMPI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Checkmate Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
Checkmate Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
From Checkmate Pharmaceuticals Inc.
Via Business Wire
Support in Place via Collaboration with Biotech Giants Regeneron and Bristol Myers Squibb for Checkmate Pharmaceuticals (NASDAQ: CMPI)
Via Get News
Support in Place via Collaboration with Biotech Giants Regeneron and Bristol Myers Squibb for Checkmate (NASDAQ: CMPI)
Support in Place via Collaboration with Biotech Giants Regeneron and Bristol Myers Squibb for Checkmate Pharmaceuticals (NASDAQ: CMPI) 
Via EIN Presswire
Topics Initial Public Offering
Exposures Securities Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.